Table IV.
Relationship between vitamin D levels and tumour characteristics
| Variable |
N = 94 n (%) |
Vitamin D mean ± SD [ng/ml] |
P-value | |
|---|---|---|---|---|
| Location of growth: | 0.139* | |||
| Cardia | 11 (12) | 14.98 ±7.11 | ||
| Body | 17 (18) | 11.27 ±5.54 | ||
| Antrum | 66 (70) | 14.30 ±5.78 | ||
| Differentiation: | 0.051* | |||
| Well | 14 (15) | 16.85 ±6.11 | ||
| Moderate | 39 (41) | 14.18 ±6.42 | ||
| Poor | 41 (44) | 12.46 ±5.12 | ||
| T stage: | 0.025** | |||
| T2 | 10 (11) | 16 ±4.99 | ||
| T3 | 18 (19) | 16.28 ±5.53 | ||
| T4 | 66 (70) | 12.83 ±6.01 | ||
| N staging: | 0.197** | |||
| N0 | 10 (10.6) | 16.33 ±5.19 | ||
| N1 | 7 (7.4) | 13.35 ±6.00 | ||
| N2 | 27 (28.7) | 14.99 ±6.63 | ||
| N3 | 50 (53.2) | 12.76 ±5.63 | ||
| Metastasis: | < 0.001*** | |||
| Present | 21 (22) | 9.82 ±5.04 | ||
| Absent | 73 (78) | 14.98 ±5.74 | ||
*
ANOVA, **Kruskal-Wallis test, ***Mann-Whitney U test.